{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:21:52Z","timestamp":1790706112919,"version":"4.1.0"},"reference-count":27,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Diffuse large B-cell lymphoma is a prevalent subtype of adult non-Hodgkin lymphoma; noted for its biological and clinical variability. Background and Objectives: This study seeks to assess the expression and prognostic implications of Ki-67, MYC, and BCL2 utilising immunohistochemistry on a cohort of Romanian patients diagnosed with DLBCL while also addressing the limitations imposed by the absence of fluorescence in situ hybridisation testing in resource-constrained settings. Materials and Methods: A single-centre, retrospective study involved 66 cases of formalin-fixed, paraffin-embedded tissue specimens obtained from patients with this lymphoma. Results: The median age at diagnosis was 61.81 years, with most individuals being 60 years or older; 59.1% of the patients were male. Our study identified that 65.2% of the cases belonged to the non-GCB subtype (ABC). MYC-positive expression was observed in 5 out of 66 cases (7.6%), and BCL2 protein expression exhibited a trend toward statistical significance, indicating a lower overall survival for BCL-2-positive patients. The expression of Ki-67 demonstrated a significant correlation with variations in overall survival (OS) (p &lt; 0.001). Patients with low Ki-67 expression had an average survival duration of 76.39 months, contrasting with individuals exhibiting high Ki-67 expression, with a mean survival of 38.98 months. In conclusion, MYC, BCL2, and Ki-67 may be valuable prognostic indicator biomarkers. Conclusions: The prognostic significance of each biomarker varies based on the established cut-off point value. Future research should examine the relationship between protein biomarkers, morphological characteristics, and clinical outcomes in Romanian patients diagnosed with DLBCL, aiming to elucidate clinical ramifications and foster effective management.<\/jats:p>","DOI":"10.3390\/medicina61060948","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:32:37Z","timestamp":1747888357000},"page":"948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlations Between Immunophenotypic Markers and Clinical Progression in Romanian Patients Diagnosed with Diffuse Large B-Cell Lymphoma"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8349-0169","authenticated-orcid":false,"given":"Georgian","family":"Halcu","sequence":"first","affiliation":[{"name":"Catedra de Anatomie Patologic\u0103, Facultatea de Medicin\u0103 General\u0103, Universitatea de Medicina si Farmacie Carol Davila Bucuresti, 050474 Bucharest, Romania"},{"name":"Spitalul Clinic Coltea Bucuresti, 030167 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Evsei-Seceleanu","sequence":"additional","affiliation":[{"name":"Catedra de Anatomie Patologic\u0103, Facultatea de Medicin\u0103 General\u0103, Universitatea de Medicina si Farmacie Carol Davila Bucuresti, 050474 Bucharest, Romania"},{"name":"Spitalul Clinic Sfanta Maria Bucuresti, 011172 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-9208","authenticated-orcid":false,"given":"Dana-Antonia","family":"Tapoi","sequence":"additional","affiliation":[{"name":"Catedra de Anatomie Patologic\u0103, Facultatea de Medicin\u0103 General\u0103, Universitatea de Medicina si Farmacie Carol Davila Bucuresti, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Cerbu","sequence":"additional","affiliation":[{"name":"Spitalul Universitar de Urgenta Bucuresti, 050098 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Barta","sequence":"additional","affiliation":[{"name":"Catedra de Anatomie Patologic\u0103, Facultatea de Medicin\u0103 General\u0103, Universitatea de Medicina si Farmacie Carol Davila Bucuresti, 050474 Bucharest, Romania"},{"name":"Spitalul Clinic Coltea Bucuresti, 030167 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-8160","authenticated-orcid":false,"given":"Mihail Constantin","family":"Ceausu","sequence":"additional","affiliation":[{"name":"Catedra de Anatomie Patologic\u0103, Facultatea de Medicin\u0103 General\u0103, Universitatea de Medicina si Farmacie Carol Davila Bucuresti, 050474 Bucharest, Romania"},{"name":"Institutul National de Endocrinologie C. I. Parhon Bucuresti, 011863 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PPO.0000000000000450","article-title":"Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma","volume":"26","author":"Roschewski","year":"2020","journal-title":"Cancer J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10428194.2023.2297939","article-title":"The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors\u2014An overview and update","volume":"65","author":"Attygalle","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12185-024-03781-5","article-title":"New classifications of B-cell neoplasms: A comparison of 5th WHO and International Consensus classifications","volume":"121","author":"Karube","year":"2025","journal-title":"Int. J. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000519074","article-title":"Application of Hans Algorithm for Subcategorization of Diffuse Large B-Cell Lymphoma in Fine-Needle Aspiration Biopsy Cytology","volume":"66","author":"Rohilla","year":"2022","journal-title":"Acta Cytol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.leukres.2012.01.022","article-title":"The Hans classificator does not predict outcome in diffuse large B cell lymphoma in a large multicenter retrospective analysis of R-CHOP treated patients","volume":"36","author":"Ott","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12308-020-00404-w","article-title":"A practical approach to FISH testing for MYC rearrangements and brief review of MYC in aggressive B-cell lymphomas","volume":"13","author":"Larson","year":"2020","journal-title":"J. Hematop."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2018-03-836361","article-title":"Double-hit DLBCL: Should we limit FISH testing?","volume":"131","year":"2018","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/jclinpath-2019-206199","article-title":"Clinical significance of \u2018double-hit\u2019 and \u2018double-expression\u2019 lymphomas","volume":"73","author":"Ma","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"ref_10","unstructured":"Hematologie, S.R.d. (2025, April 05). Ghiduri Terapeutice limfoproliferari Cronice 2011. Available online: https:\/\/app.srh.org.ro\/fisiere_ghid\/document_19.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.31557\/APJCP.2019.20.5.1463","article-title":"C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma","volume":"20","author":"Mohammed","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjh.14250","article-title":"MYC and BCL2 evaluation in routine diagnostics of aggressive B-cell lymphomas\u2014Presentation of a work-flow and the experience with 248 cases","volume":"179","author":"Menter","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 Protein Coexpression Contributes to the Inferior Survival of Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma and Demonstrates High-Risk Gene Expression Signatures: A Report From the International DLBCL Rituximab-Chop Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2005.03.4264","article-title":"BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma","volume":"24","author":"Iqbal","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_15","first-page":"837","article-title":"The prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma","volume":"58","author":"Patrascu","year":"2017","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2307\/2340521","article-title":"On the interpretation of X2 from Contingency Tables, and the Calculation of P","volume":"85","author":"Fisher","year":"1922","journal-title":"J. R. Stat. Soc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","article-title":"Asymptotically Efficient Rank Invariant Test Procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J. R. Stat. Soc. Ser. A (Gen.)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. Ser. B (Methodol.)"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yimpak, P., Bumroongkit, K., Tantiworawit, A., Rattanathammethee, T., Aungsuchawan, S., and Daroontum, T. (2024). Immunohistochemistry-based investigation of MYC, BCL2, and Ki-67 protein expression and their clinical impact in diffuse large B-cell lymphoma in upper Northern Thailand. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0307253"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00428-020-02931-4","article-title":"Artificial intelligence to detect MYC translocation in slides of diffuse large B-cell lymphoma","volume":"479","author":"Hebeda","year":"2021","journal-title":"Virchows Arch."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2016.71","article-title":"Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression","volume":"29","author":"Valera","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.seminhematol.2018.05.007","article-title":"Diagnosis and classification of lymphoma: Impact of technical advances","volume":"56","author":"Jaffe","year":"2019","journal-title":"Semin. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2020.274258","article-title":"Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma","volume":"107","author":"Ma","year":"2022","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.3390\/curroncol28060383","article-title":"Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study","volume":"28","author":"Huber","year":"2021","journal-title":"Curr. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2014.1.90","article-title":"Diagnosis of \u2018double hit\u2019 diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: When and how, FISH versus IHC","volume":"2024","author":"Swerdlow","year":"2014","journal-title":"Hematol.-Am. Soc. Hematol. Educ. Program"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:38:08Z","timestamp":1760031488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61060948"],"URL":"https:\/\/doi.org\/10.3390\/medicina61060948","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}